VJ

Vijay Jogeshwar Yadav

Active Director Director DIN 10702023
DIN 10702023 First appointment Jul 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Vijay Jogeshwar Yadav

Data last updated:

Vijay Jogeshwar Yadav is a Director at Lifecura Pharma India Private Limited (since 2024). Lifecura Pharma India Private Limited reported revenue of ₹2.54 Cr (FY 2025).

DIN 10702023
Primary Designation Director
First Appointment 10 Jul 2024
Oldest Company Age 2 yrs
Largest company Lifecura Pharma India Private Limited · ₹2.54 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20242024₹2.54 Cr (FY 2025)Active

Board colleagues of Vijay Jogeshwar Yadav

NameDINCompanyDesignation
Jitendra Yadav09471950Lifecura Pharma India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lifecura Pharma India Private Limited
Premium access

Shareholding and investment profile for Vijay Jogeshwar Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Jogeshwar Yadav

Vijay Jogeshwar Yadav currently holds 1 directorship: Lifecura Pharma India Private Limited (Director, since 10 Jul 2024, revenue ₹2.54 Cr (FY 2025)).

Vijay Jogeshwar Yadav was first appointed on 10 Jul 2024 as Director at Lifecura Pharma India Private Limited.

The current boards of Vijay Jogeshwar Yadav's companies include Jitendra Yadav (Lifecura Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available